Sacubitril And Valsartan Tablet, Film Coated
Product Images NDC 82293-040

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Sacubitril And Valsartan (NDC 82293-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novugen Pharma (usa) Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure0001)

A chart showing geometric mean ratios and 90% confidence intervals for pharmacokinetic parameters (AUC and Cmax) of various coadministered drugs with Sacubitril and Valsartan. Drugs listed include Furosemide, Warfarin, Digoxin, Carvedilol, Levonorgestrel, Ethinyl estradiol, Amlodipine, HCTZ, Metformin, Atorvastatin, and Sildenafil. The x-axis represents change relative to reference values.*

FDA Label Image

Image Description (Figure0003)

Three Kaplan-Meier cumulative failure rate graphs from the PARADIGM-HF study comparing Sacubitril and Valsartan Tablets with Enalapril over time. Figure A shows time to first occurrence of cardiovascular death or heart failure hospitalizations; Figure B shows time to occurrence of cardiovascular death; Figure C shows time to first occurrence of heart failure hospitalizations. Each chart includes number at risk at various time points and hazard ratios with confidence intervals.*

FDA Label Image

Image Description (Figure0004)

A forest plot chart showing the comparative hazard ratios of Sacubitril and Valsartan tablets versus Enalapril across various patient subgroups. The chart displays subgroups by age, gender, weight, race, region, heart failure class, kidney function, diabetes status, blood pressure, ejection fraction, atrial fibrillation, biomarkers, hypertension, prior medication use, and heart failure history. Each subgroup includes point estimates and 95% confidence intervals for hazard ratios, indicating relative treatment effect between Sacubitril and Valsartan and Enalapril.*

FDA Label Image

Image Description (Figure0005)

A line graph depicting the mean number of total heart failure hospitalizations and cardiovascular deaths per 100 patients over time in days since randomization, comparing Sacubitril and Valsartan Tablets with Valsartan alone in the PARAGON-HF study. The graph includes a table showing the number of patients at risk at various time points for both treatment groups.*

FDA Label Image

Image Description (Figure0006)

A forest plot comparing Sacubitril and Valsartan Tablets with Valsartan across various subgroups. The plot displays rate ratios and 95% confidence intervals for age, gender, race, region, diabetes status, baseline measures (LVEF, AF, NT-proBNP, SBP, eGFR), and NYHA class, indicating relative effectiveness between the treatments.*

FDA Label Image

Image Description (Figure0007)

A two-part line graph comparing hazard ratios with 95% confidence intervals for sacubitril versus enalapril and sacubitril versus valsartan in valsartan tablets, plotted against the left ventricular ejection fraction at screening (%) for heart failure studies PARADIGM-HF and PARAGON-HF.*

FDA Label Image

Figure 2 (Figure02)

A figure showing the geometric mean ratio and 90% confidence intervals for AUC and Cmax across various population subgroups. The subgroups include renal impairment (mild, moderate, severe), hepatic impairment (mild, moderate), age groups (≥65 years vs 18-45 years), sex (male/female), and race (Asian vs Caucasian, Black vs Caucasian). The chart compares these changes relative to reference for two treatments, LBQ657 and Valsartan.*

FDA Label Image

24mg/26mg Blister (Image0003)

Sacubitril and Valsartan 24 mg/26 mg film-coated tablet labels with black text on a white background featuring the product name, strength, labeler Novugen Pharma (USA) LLC, lot number and expiration date placeholders, barcodes, and manufacturing details. The labels are arranged in two rows of five. Tablets are for oral use.*

FDA Label Image

49mg/51mg Blister (Image0007)

A label sheet containing multiple identical labels for Sacubitril and Valsartan 49 mg/51 mg film-coated tablets. Each label includes the product name, strength, dosage form, manufacturer Novugen Pharma (USA) LLC, product NDC 82293-040, space for lot number and expiration date, and barcodes. The labels are arranged in a grid format with perforated edges for separation.*

FDA Label Image

24mg/26mg 60's (Image001)

Label for Sacubitril and Valsartan Tablets 24 mg/26 mg film-coated tablets. The label indicates 60 tablets per package and is for prescription use only. Distributed by Novugen Pharma (USA) LLC. The label includes dosage details, storage instructions, and a barcode.*

FDA Label Image

97 mg/103 mg (180's)

Sacubitril and Valsartan Tablets 97 mg/103 mg film-coated tablets in a package containing 180 tablets. The label shows storage instructions, manufacturer as Novugen Pharma (USA) LLC, Princeton, NJ, and indicates the product is made in India. The package is child-resistant and for prescription use only.*

FDA Label Image

I24mg/26mg 180's (Image002)

Label for Sacubitril and Valsartan Tablets, 24 mg/26 mg strength, film-coated oral tablets. The package contains 180 tablets and is marked Rx only. Distributed by Novugen Pharma (USA) LLC with address in Princeton, NJ, and made in India. The label includes dosage information, storage instructions, child-resistant packaging note, and barcode with area for over coding and variable data matrix.*

FDA Label Image

49mg/51mg 60's (Image005)

Label for Sacubitril and Valsartan Tablets, 49 mg/51 mg film-coated tablets. The package contains 60 tablets and is labeled for prescription use only. Distributed by Novugen Pharma (USA) LLC, Princeton, NJ. The label includes dosage information, storage instructions, and barcodes alongside a QR code for batch details with serialization.*

FDA Label Image

49mg/51mg 180's (Image006)

Label for Sacubitril and Valsartan Tablets, 49 mg/51 mg strength, film-coated oral tablets. The package contains 180 tablets and is distributed by Novugen Pharma (USA) LLC. The label includes dosage information, storage instructions, and child-resistant packaging details. The product is labeled Rx only and includes barcodes and batch tracking zones.*

FDA Label Image

97 mg/103 mg Blister (Image011)

Label for Sacubitril and Valsartan tablets, film-coated, strength 97 mg/103 mg. Distributed by Novugen Pharma (USA) LLC, Princeton, NJ. The label shows a barcode, lot and expiration placeholders, and indicates the tablets are made in India. The format includes multiple identical labels on a single sheet.*

FDA Label Image

97 mg/103 mg Carton (Image012)

Sacubitril and Valsartan Tablets 97 mg/103 mg film-coated oral tablets packaging label by Novugen Pharma (USA) LLC. The label states 100 tablets per package (10 x 10 Count Unit-Dose) with NDC 82293-040-30. The label includes storage instructions, dosage information, and a barcode.*

FDA Label Image

24 mg/26 mg (carton)

Packaging label for Sacubitril and Valsartan tablets, 24 mg/26 mg strength, film-coated oral tablets. The label indicates a package size of 100 tablets (10 x 10 count unit-dose) and includes storage instructions and manufacturer information for Novugen Pharma (USA) LLC. It is marked Rx only and states the package is not child-resistant.*

FDA Label Image

49mg/51mg Carton (Image08)

Packaging label for Sacubitril and Valsartan Tablets 49 mg/51 mg by Novugen Pharma (USA) LLC. The label indicates a film-coated tablet dosage form, Rx only, with 100 tablets per package (10 x 10 count unit-dose). The label shows storage instructions, NDC 82293-028-30, and states the product is made in India.*

FDA Label Image

97 mg/103 mg (60's)

Sacubitril and Valsartan Tablets, 97 mg/103 mg film-coated tablets, presented in a package containing 60 tablets. The label states the labeler as Novugen Pharma (USA) LLC and notes the product is Rx only. The packaging includes dosage and storage instructions, barcode, and batch information with a 2D data matrix code area.*

FDA Label Image

Sacubitril Sodium (Structure0001)

Chemical structure of Sacubitril and Valsartan, showing its molecular framework with labeled stereochemistry (S and R configurations), ester, amide, and carboxylate functional groups.*

FDA Label Image

Valsartan Disodium (Structure0002)

Chemical structure diagram of Sacubitril and Valsartan showing molecular bonds, ring structures, and associated sodium and water components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.